These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 34784010)
1. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma. Liang Z; Li X; Duan F; Song L; Wang Z; Li X; Yang P; Li L Hum Cell; 2022 Jan; 35(1):299-309. PubMed ID: 34784010 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047 [TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA Gong X; Zhu Z Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535 [No Abstract] [Full Text] [Related]
4. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis. Zhu Y; Zhao J; Tan L; Lin S; Long M; Peng X Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591 [TBL] [Abstract][Full Text] [Related]
7. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma. Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
9. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression. Qian X; Wang Y; Hu W; Xu X; Gao L; Meng Y; Yan J Tissue Cell; 2022 Feb; 74():101721. PubMed ID: 34979376 [TBL] [Abstract][Full Text] [Related]
10. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p. Yao J; Fu J; Liu Y; Qu W; Wang G; Yan Z Ann Hepatol; 2021; 23():100297. PubMed ID: 33346094 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma. Wu J; Huang J; Wang W; Xu J; Yin M; Cheng N; Yin J Cancer Biomark; 2017 Jul; 20(1):55-65. PubMed ID: 28759956 [TBL] [Abstract][Full Text] [Related]
12. Targeting GPR133 Zhang S; Zhang Y; Sun X Int J Neurosci; 2024 Sep; 134(9):991-1002. PubMed ID: 37036013 [No Abstract] [Full Text] [Related]
13. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
14. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G; Lin Y; Zhang H; Wu D Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123 [TBL] [Abstract][Full Text] [Related]
15. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Shi Y; Yan F; Wang F; Pan L Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762 [TBL] [Abstract][Full Text] [Related]
16. miR-3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial-mesenchymal transition process. Hu WY; Wei HY; Liu LY; Li KM; Wang RB; Xu XQ; Feng R IUBMB Life; 2020 Aug; 72(8):1686-1697. PubMed ID: 32311821 [TBL] [Abstract][Full Text] [Related]
17. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y; Chen G; Yan Y; Fan Q Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158 [TBL] [Abstract][Full Text] [Related]
18. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
19. miR-664b-5p Inhibits Hepatocellular Cancer Cell Proliferation Through Targeting Oncogene AKT2. Li H; Guo D; Zhang Y; Yang S; Zhang R Cancer Biother Radiopharm; 2020 Oct; 35(8):605-614. PubMed ID: 31967930 [No Abstract] [Full Text] [Related]
20. MiR-503-5p regulates cell epithelial-to-mesenchymal transition, metastasis and prognosis of hepatocellular carcinoma through inhibiting WEE1. Jiang SP; Li ZR Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2028-2037. PubMed ID: 30915746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]